Switching from Ustekinumab to Risankizumab Improves Outcomes in Crohn's Disease: A Single-Centre Real-World Data Analysis

被引：0
|
作者：
Qazi, U. [1 ]
Padley, J. [1 ]
Colwill, M. [1 ,2 ]
Mehta, S. [1 ]
Donovan, F. [1 ]
Alves, A. M. Francisco [1 ]
Pollok, R. [1 ,2 ]
Poullis, A. [1 ,2 ]
Patel, K. [1 ]
Honap, S. [1 ,3 ]
机构：
[1] St Georges Univ Hosp NHS Fdn Trust, Gastroenterol, London, England
[2] City St Georges Univ London, Inst Infect & Immun, London, England
[3] Kings Coll London, Sch Immunol & Microbial Sci, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1269
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1095
引用
收藏
页码：i2012 / i2012
页数：1
相关论文
共 50 条
  • [21] Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTE
    Bello, F.
    Lordal, M.
    Johansson, F.
    Sabhan, H.
    Muhsen, S.
    Borin, A.
    Forsberg, O.
    Wennerstrom, C.
    Soderman, C.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I130 - I131
  • [22] Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease
    Srinivasan, Ashish
    van Langenberg, Daniel
    De Cruz, Peter
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (06) : E69 - E69
  • [23] A MULTICENTER STUDY OF THE REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN CROHN'S DISEASE
    Askar, Manar
    Belani, Seema
    Devi, Jalpa
    Huang, Katherine
    Khan, Abdul
    Said, Hyder
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Fenster, Marc
    Ungaro, Ryan C.
    Yarur, Andres
    Deepak, Parakkal
    Johnson, Amanda M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1143 - S1144
  • [24] Early Observations in the Real-World Use of Risankizumab Therapy for Crohn's Disease
    Leone, Anna
    Drosdak, Alyssa
    Chiplunker, Adeeti
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S757 - S758
  • [25] Efficacy and safety of ustekinumab in Crohn's disease: A real-world study from Australia
    Ramaswamy, P. Kakkadasam
    Moattar, H.
    Sawyer, E.
    Edwards, J.
    Shukla, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S564 - S565
  • [26] Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn's disease patients
    Liefferinckx, C.
    Fassin, M.
    Thomas, D.
    Minsart, C.
    Cremer, A.
    Amininejad, L.
    Tafciu, V.
    Wambacq, V.
    Van Gossum, A.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S331 - S333
  • [27] Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort
    Plevris, Nikolas
    Fulforth, James
    Siakavellas, Spyros
    Robertson, Andrew
    Hall, Rebecca
    Tyler, Amy
    Jenkinson, Philip W.
    Campbell, Iona
    Chuah, Cher Shiong
    Kane, Claire
    Veryan, Jennifer
    Lam, Wai Liam
    Saunders, Jayne
    Kelly, Christopher
    Gaya, Daniel
    Jafferbhoy, Hasnain
    Macdonald, Jonathan C.
    Seenan, John Paul
    Mowat, Craig
    Naismith, Graham
    Potts, Lindsay F.
    Sutherland, Diarmid Ian
    Watts, David
    Arnott, Ian
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2067 - 2075
  • [28] Outcomes of dupilumab screening and monitoring: a real-world single-centre experience
    Al-Janabi, A.
    Stylianou, K.
    Kreeshan, F.
    Warren, R.
    Hunter, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 71 - 71
  • [29] Ustekinumab: "Real-world" outcomes and potential predictors of nonresponse in treatment-refractory Crohn's disease
    Hoffmann, Peter
    Krisam, Johannes
    Wehling, Cyrill
    Kloeters-Plachky, Petra
    Leopold, Yvonne
    Belling, Nina
    Gauss, Annika
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (31) : 4481 - 4492
  • [30] Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn's disease
    Peter Hoffmann
    Johannes Krisam
    Cyrill Wehling
    Petra Kloeters-Plachky
    Yvonne Leopold
    Nina Belling
    Annika Gauss
    World Journal of Gastroenterology, 2019, (31) : 4481 - 4492
12345